Drug regulatory harmonization in biopharmaceutics is a crucial aspect of ensuring the consistent and efficient evaluation and approval of biopharmaceutical products across different regions. Biopharmaceutics focuses on understanding the relationship between the drug formulation, its release, and the subsequent therapeutic effect in the human body. Harmonizing regulations in this field facilitates a streamlined and standardized approach to assessing the safety, efficacy, and quality of biopharmaceuticals.
By aligning regulatory requirements, countries can minimize redundancies in the approval process, encourage innovation, and expedite patient access to advanced biopharmaceutical therapies. This harmonization enhances collaboration among regulatory authorities, promotes information exchange, and fosters a global framework for evaluating the complex nature of biopharmaceuticals. Ultimately, a harmonized approach ensures that patients worldwide benefit from timely access to cutting-edge biopharmaceutical treatments, advancing healthcare on a global scale.
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Yong Xiao Wang
Albany Medical College, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Huiqin Yang
ICON Clinical Research Ltd, United KingdomSubmit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Antibody proteases as translational tools of the next step generation to be applied for biopharmacy related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India
Title : Cognitivevoice: Novel machine learning model leveraging acoustic features to predict future cognitive decline in Parkinson’s Disease
Aadya Daga, Hamilton High School, United States
Title : Platelet-activating factor-receptor pathway mediates solar radiation-induced extracellular vesicle release in human keratinocytes
Ravi P Sahu, Wright State University, United States